Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

BACKGROUND: Brain metastases are a common cause of disabling neurologic complications and death in patients with metastatic melanoma. Previous studies of nivolumab combined with ipilimumab in metastatic melanoma have excluded patients with untreated brain metastases. We evaluated the efficacy and sa...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:N Engl J Med
मुख्य लेखकों: Tawbi, Hussein A., Forsyth, Peter A., Algazi, Alain, Hamid, Omid, Stephen Hodi, F., Moschos, Stergios J., Khushalani, Nikhil I., Lewis, Karl, Lao, Christopher D., Postow, Michael A., Atkins, Michael B., Ernstoff, Marc S., Reardon, David A., Puzanov, Igor, Kudchadkar, Ragini R., Thomas, Reena P., Tarhini, Ahmad, Pavlick, Anna C., Jiang, Joel, Avila, Alexandre, Demelo, Sheena, Margolin, Kim
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2018
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011001/
https://ncbi.nlm.nih.gov/pubmed/30134131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1805453
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन